Global HEOR Leader | Elevating Global Access Through Data-Powered Economic Evaluations & Strategies | Global Trusted Partner
The webinar Syenza hosted last week was on medicine price transparency and pathways to fair pricing. The webinar started with an explanation of transparent medicine pricing and a quantitative definition for fair pricing. We had people joining from all around the globe, appreciated, guys! We also reviewed managed entry agreements and direct price negotiations, specifically the US Inflation Reduction Act. I gave an update on a recent paper I published in the Journal of Medical Economics with inspiration from discussions at the WHO Fair Pricing Forum. The session wasn't all about listening - there were polls to see what each participant thought about the most important strategies and challenges, like whether transparent policies would result in affordable health care. Check out the video below for more details. #SyenzaEvents #pharmaceuticals #medtech #healthtech #oncology #innovation
Divisional Head @ | Cardio-Metabolic Diseases Portfolio
1wThanks João. Looking forward to more of this. Very interesting. We all know that extreme transparency in pricing lowers medicine costs. But one must establish a balance in terms of pricing being weary that pricing may stifle innovation if MEA’s are not in place.